- Intolerance to Sunitinib Treatment in Hemodialysis Patients With Metastatic Renal Cell Carcinoma
-
Yildiz I, Sen F, Kilic L, Ciftci R, Basaran M
- KMID: 1988457
- Korean J Urol.
- 2014 Jan;55(1):74-76.
- doi: 10.4111/kju.2014.55.1.74
Sunitinib is a multiple tyrosine kinase receptor inhibitor that is approved for the treatment of metastatic renal cell carcinoma (RCC). However, neither an appropriate dose nor dosing schedule of sunitinib... -
- CITED
-
- Close
- SHARE
-
- Close
